German General Merchandise and Department Stores Stock News

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

ATOSS Software (XTRA:AOF) reported a net profit margin of 25.7%, just above last year’s 25.2%. Earnings growth has averaged 25.8% annually over the past five years, although the most recent year saw a 12.5% gain. With forecasts pointing to 13.5% annual earnings growth and revenue projected to grow 12% per year, outpacing the wider German market, investors are watching how these strong fundamentals balance against a premium valuation multiple and elevated share price. See our full analysis for...

If you’ve been watching Symrise stock lately, you’re not alone in wondering whether now is the right time to make a move. After all, the company’s share price has jumped 3.0% in the last week and 7.2% over the past month. Yet, when you zoom out, the bigger picture is more complex. Year to date, Symrise is down about 20.8%, and over the last five years, it has slipped by more than 20%. These numbers might make you pause and ask what’s really driving the stock’s story right now. Some of this...

TeamViewer (XTRA:TMV) posted robust earnings, with net profit margins rising to 17.8% from 16.3% a year ago. Over the last five years, annual earnings have grown by 11.1%, while the most recent twelve months saw a 19.6% jump in earnings. With earnings forecast to grow by 14.1% per year and revenue expected to increase at 7.7% annually, outpacing the broader German market, investors have plenty of growth drivers to watch. At the same time, share price and financial stability risks remain part...

Key Insights Significantly high institutional ownership implies LANXESS' stock price is sensitive to their trading...

IONOS Group SE ( ETR:IOS ), might not be a large cap stock, but it saw significant share price movement during recent...

While Elmos Semiconductor SE ( ETR:ELG ) might not have the largest market cap around , it saw a decent share price...

Key Insights Significantly high institutional ownership implies Fresenius SE KGaA's stock price is sensitive to their...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Beiersdorf fair value estimate is €129 Current share price of...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

While ATOSS Software SE ( ETR:AOF ) might not have the largest market cap around , it received a lot of attention from...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Most readers would already be aware that PVA TePla's (ETR:TPE) stock increased significantly by 41% over the past three...

On October 13, 2025, SQ Innovation received FDA approval for Lasix ONYU, a combination product featuring Gerresheimer’s proprietary on-body infusor for at-home subcutaneous drug delivery in select congestive heart failure patients. This milestone showcases Gerresheimer’s technological capabilities in advanced drug delivery devices and highlights its growing position as a full-service partner to pharmaceutical companies embracing home-based care. Next, we’ll explore how the FDA-backed rollout...

It's easy to match the overall market return by buying an index fund. While individual stocks can be big winners...

Jenoptik AG ( ETR:JEN ) shareholders should be happy to see the share price up 18% in the last month. But that doesn't...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Most readers would already be aware that ad pepper media International's (ETR:APM) stock increased significantly by 20...

Ceconomy AG was recently removed from the Germany Small DAX (Total Return) Index, changing its status among tracked German equities. This exclusion may affect its visibility and demand from funds that track the index, influencing the company’s relationship with institutional investors. We’ll explore how Ceconomy's index removal may impact its investment case, especially regarding its profile among index-oriented investors. We've found 18 US stocks that are forecast to pay a dividend yield of...

Gerresheimer (XTRA:GXI) shares drew renewed attention after news that the US FDA approved the Lasix ONYU combination product, which features the company’s proprietary on-body drug delivery device. This regulatory win could prove commercially meaningful with 2025 launches approaching. See our latest analysis for Gerresheimer. Despite the lift from FDA approval of its new drug delivery device, Gerresheimer's share price has continued to face heavy pressure, with a 30-day share price return of...

Key Insights Given the large stake in the stock by institutions, SUSS MicroTec's stock price might be vulnerable to...

If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? Businesses...

adesso SE ( ETR:ADN1 ), is not the largest company out there, but it saw a significant share price rise of 23% in the...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...